Hemostasis/Coagulation Analyzer Market

Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025

Report Code: AST 7689 Jun, 2020, by marketsandmarkets.com

[155 Pages Report] The global coagulation analyzers market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. Emerging economies such as India, China, and Brazil are expected to provide a wide range of opportunities for players in the industry. Furthermore, the increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population are expected to boost the growth of this market in the coming years.

Coagulation Analyzers Market - Attractive Opportunities

Prothrombin time tests accounted for the largest market share in 2019

In 2019, the prothrombin time testing segment accounted for the largest share of the coagulation analyzers market. Growth in this market segment can be attributed to the high usage of prothrombin time tests in measuring the time it takes for blood to clot. These tests are used to monitor patients implanted with mechanical heart valves, ventricular assist devices, chronic atrial fibrillation, venous embolism and thrombosis of deep vessels of lower extremities, deep venous thrombosis, and pulmonary embolism.

Clinical laboratories segment dominated the coagulation analyzers market in 2019

On the basis of end user, the coagulation analyzers market is segmented into clinical laboratories, hospitals, and other end users. In 2019, the clinical laboratories segment accounted for the largest share of the coagulation analyzers market. This can be attributed to the large volume of coagulation testing being performed at these facilities.

Coagulation Analyzers Market - By Region

Asia Pacific market to grow at the highest rate from 2020 to 2025

The coagulation analyzers market in the Asia Pacific is expected to grow at a high CAGR in the coming years. The factors contributing to the high growth of this market include the rising incidence/prevalence of blood-related disorders, increasing government initiatives for the improvement of healthcare infrastructure, rising number of general surgeries, and growth in research activities in several Asia Pacific countries. Moreover, the rapidly growing geriatric population (and the subsequent increase in the incidence of thalassemia, sickle-cell anemia, and leukemia) and healthcare infrastructure improvements in countries such as Japan, China, and Australia are expected to support the growth of this market in the coming years.

Key Market Players

The major players operating in the coagulation analyzers market are Abbott Laboratories (US), Danaher (US), Siemens Healthineers Group (Germany), Sysmex Group (US), Thermo Fisher Scientific (US), Horiba (Japan), Nihon Kohden (Japan), Roche Diagnostics (Switzerland), Maccura Biotechnology Co. Ltd. (China), Bio Group Medical System (Italy), Genrui Biotech Inc. (China),  A&T Corporation (Japan), Beijing Succeeder Technology Inc. (China), Diagnostica Stago SAS (France),  Helena Laboratories (US), Hycel (Austria), Eurolyser (Austria), Bpc Biosed Srl (Italy), Robimes India Pvt. Ltd (India), Meril Life Sciences (India), ERBA Diagnostics, Inc. (US), Sclavo Diagnostics International S.r.l (Italy), Haematonics (US), Biosystems S.A. (Spain), and ACON (US).

Scope of the Report

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD)

Segments Covered

Test, Product, Technology, End User, and Region

Geographies Covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa

Companies Covered

Abbott Laboratories (US), Danaher (US), Siemens Healthineers Group (Germany), Sysmex Group (US), Thermo Fisher Scientific (US), Horiba (Japan), Nihon Kohden (Japan), Roche Diagnostics (Switzerland), Maccura Biotechnology Co. Ltd. (China), Bio Group Medical System (Italy), Genrui Biotech Inc. (China),  A&T Corporation (Japan), Beijing Succeeder Technology Inc. (China), Diagnostica Stago SAS (France),  Helena Laboratories (US), Hycel (Austria), Eurolyser (Austria), Bpc Biosed Srl (Italy), Robimes India Pvt. Ltd. (India), Meril Life Sciences (India), ERBA Diagnostics, Inc. (US), Sclavo Diagnostics International S.r.l (Italy), Haematonics (US), Biosystems S.A. (Spain), and ACON (US).

This research report categorizes the coagulation analyzers market into the following segments:

Coagulation Analyzers Market, by Product

  • Clinical Laboratory Analyzers
    • Consumables
      • Reagents
      • Standards, Controls, and Calibrations
    • Systems
      • Automated Systems
      • Manual Systems
      • Semi-automated Systems
  • Point-of-care Testing Analyzers

Coagulation Analyzers Market, by Test

  • Prothrombin Time Testing
  • Fibrinogen Testing
  • Activated Clotting Time Testing
  • Activated Partial Thromboplastin Time Testing
  • D-dimer Testing
  • Platelet Function Tests
  • Anti-Factor XA Tests
  • Heparin & Protamine Dose-response Tests for ACT
  • Other Coagulation Tests

Coagulation Analyzers Market, by Technology

  • Optical
  • Mechanical
  • Electrochemical
  • Other Technologies
  • Coagulation Analyzers Market, by End User
  • Clinical Laboratories
  • Hospitals
  • Other End Users

Coagulation Analyzers Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments:

  • In 2019, Nihon Kohden established a hematology analyzer reagent factory in Dubai.
  • In 2018, Sysmex  launched the Automated Blood Coagulation Analyzers CN-6000 and CN-3000
  • In 2017, Roche Diagnostics launched the cobas t 711 coagulation analyzer

Key Questions Addressed in the Report:

  • What are the growth opportunities in the coagulation analyzers market across major regions in the coming years?
  • Emerging countries have immense opportunities for the growth and adoption of coagulation analyzers. Will this scenario continue during the next five years?
  • What are the various coagulation analyzers and their respective market shares in the overall market?
  • What are the new trends and advancements in the coagulation analyzers market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst


TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 17)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES MADE

2 RESEARCH METHODOLOGY (Page No. - 21)
    2.1 RESEARCH APPROACH
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Breakdown of primaries
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 28)

4 PREMIUM INSIGHTS (Page No. - 32)
    4.1 COAGULATION ANALYZERS MARKET OVERVIEW
    4.2 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT & COUNTRY (2020)
    4.3 COAGULATION ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW (Page No. - 34)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of cardiovascular diseases and blood disorders
                    5.2.1.2 Rising geriatric population
                    5.2.1.3 Technological advancements
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of fully automated coagulation analyzers
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets
                    5.2.3.2 Growing reagent rental business
           5.2.4 CHALLENGES
                    5.2.4.1 Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches

6 COAGULATION ANALYZERS MARKET, BY PRODUCT (Page No. - 40)
    6.1 INTRODUCTION
    6.2 CLINICAL LABORATORY ANALYZERS
           6.2.1 CONSUMABLES
                    6.2.1.1 Reagents
                               6.2.1.1.1 Reagents accounted for the largest share of the consumables market in 2019
                    6.2.1.2 Standards, Controls, and Calibrations
                               6.2.1.2.1 Standards, controls, and calibrations play an important role in ensuring the performance and accuracy of instruments
           6.2.2 SYSTEMS
                    6.2.2.1 Automated systems
                               6.2.2.1.1 Fully automated systems deliver results with high accuracy and precision in shorter periods
                    6.2.2.2 Semi-automated systems
                               6.2.2.2.1 Cost-effectiveness of semi-automated systems to drive their adoption
                    6.2.2.3 Manual systems
                               6.2.2.3.1 Manual systems to witness lower growth during the forecast period
    6.3 POINT-OF-CARE TESTING ANALYZERS
           6.3.1 POC TESTING ANALYZERS TO WITNESS HIGH DEMAND GROWTH IN THE COMING YEARS

7 COAGULATION ANALYZERS MARKET, BY TEST (Page No. - 50)
    7.1 INTRODUCTION
    7.2 PROTHROMBIN TIME TESTING
           7.2.1 PT/INR TESTS DOMINATED THE MARKET IN 2019
    7.3 D-DIMER TESTING
           7.3.1 D-DIMER TESTS ARE USED TO CHECK BLOOD CLOTTING ISSUES
    7.4 FIBRINOGEN TESTING
           7.4.1 GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO INCREASE THE DEMAND FOR FIBRINOGEN TESTS
    7.5 ACTIVATED CLOTTING TIME TESTING
           7.5.1 ACT TESTS HELP HEALTHCARE PROVIDERS TO FIND THE RIGHT DOSAGE OF HEPARIN
    7.6 ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING
           7.6.1 GROWING NUMBER OF ANGIOPLASTY AND DIALYSIS PROCEDURES TO SUPPORT MARKET GROWTH
    7.7 PLATELET FUNCTION TESTS
           7.7.1 PLATELET FUNCTION TESTS ARE PERFORMED TO EVALUATE THE ABILITY OF PLATELETS TO CLUMP TOGETHER
    7.8 ANTI-FACTOR XA TESTS
           7.8.1 ANTI-FACTOR XA TESTS AID IN THE MONITORING OF STANDARD HEPARIN THERAPY FOR UFH
    7.9 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT
           7.9.1 DUE TO LIMITED APPLICATIONS, THIS TEST SEGMENT HAS A VERY SMALL SHARE IN THE COAGULATION ANALYZERS MARKET
    7.10 OTHER COAGULATION TESTS

8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY (Page No. - 62)
    8.1 INTRODUCTION
    8.2 OPTICAL TECHNOLOGY
           8.2.1 OPTICAL TECHNOLOGY SEGMENT DOMINATED THE MARKET IN 2019
    8.3 MECHANICAL TECHNOLOGY
           8.3.1 MECHANICAL ANALYZERS ARE NOT AFFECTED BY ICTERIC OR LIPEMIC PLASMA
    8.4 ELECTROCHEMICAL TECHNOLOGY
           8.4.1 INCREASING DEMAND FOR SELF-TESTING TO DRIVE MARKET GROWTH
    8.5 OTHER TECHNOLOGIES

9 COAGULATION ANALYZERS MARKET, BY END USER (Page No. - 67)
    9.1 INTRODUCTION
    9.2 HOSPITALS
           9.2.1 HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH
    9.3 CLINICAL LABORATORIES
           9.3.1 CLINICAL LABORATORIES FORMED THE LARGEST END-USER SEGMENT IN THIS MARKET
    9.4 OTHER END USERS

10 COAGULATION ANALYZERS MARKET, BY REGION (Page No. - 71)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
                       10.2.1.1 Favorable research scenario will drive market growth in the US
             10.2.2 CANADA
                       10.2.2.1 Rising demand for blood and blood components to support market growth
     10.3 EUROPE
             10.3.1 GERMANY
                       10.3.1.1 Increasing incidence of HIV is a major factor driving the growth of the coagulation analyzers market in Germany
             10.3.2 UK
                       10.3.2.1 Government support to develop innovative diagnostic kits will boost market growth in the UK
             10.3.3 FRANCE
                       10.3.3.1 Presence of proper protocols and guidelines for diagnostics to propel market growth in France
             10.3.4 ITALY
                       10.3.4.1 Increasing preference for coagulation testing during transplantation will result in market growth
             10.3.5 SPAIN
                       10.3.5.1 Consolidation of laboratories in Spain will drive market growth
             10.3.6 REST OF EUROPE
     10.4 ASIA PACIFIC
             10.4.1 CHINA
                       10.4.1.1 Government initiatives and improving healthcare infrastructure to aid market growth
             10.4.2 JAPAN
                       10.4.2.1 Rising POC testing will contribute to market growth in Japan
             10.4.3 INDIA
                       10.4.3.1 High burden of chronic diseases to support market growth
             10.4.4 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA
             10.5.1 DEARTH OF QUALIFIED HEALTHCARE PROFESSIONALS TO RESTRAIN MARKET GROWTH IN LATAM
     10.6 MIDDLE EAST & AFRICA
             10.6.1 HIGH PREVALENCE OF BLOOD DISORDERS TO SUPPORT MARKET GROWTH IN THE MEA

11 COMPETITIVE LANDSCAPE (Page No. - 109)
     11.1 OVERVIEW
     11.2 MARKET RANKING ANALYSIS
     11.3 COMPETITIVE LEADERSHIP MAPPING
             11.3.1 VISIONARY LEADERS
             11.3.2 INNOVATORS
             11.3.3 DYNAMIC DIFFERENTIATORS
             11.3.4 EMERGING COMPANIES
     11.4 COMPETITIVE SITUATION AND TRENDS
             11.4.1 PRODUCT LAUNCHES AND ENHANCEMENTS
             11.4.2 PARTNERSHIPS AND AGREEMENTS
             11.4.3 MERGERS & ACQUISITIONS

12 COMPANY PROFILES (Page No. - 115)
(Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view)*
     12.1 ABBOTT LABORATORIES
     12.2 THERMO FISHER SCIENTIFIC, INC.
     12.3 NIHON KOHDEN CORPORATION
     12.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
     12.5 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
     12.6 SYSMEX CORPORATION
     12.7 DANAHER CORPORATION
     12.8 HORIBA
     12.9 DIAGNOSTICA STAGO SAS
     12.10 HELENA LABORATORIES CORPORATION
     12.11 MACCURA BIOTECHNOLOGY CO., LTD.
     12.12 BEIJING SUCCEEDER TECHNOLOGY INC.
     12.13 HYCEL HANDELSGES.M.B.H.
     12.14 GENRUI BIOTECH INC.
     12.15 ERBA DIAGNOSTICS MANNHEIM GMBH (A TRANSASIA BIO-MEDICALS LTD. COMPANY)
     12.16 BIO-GROUP MEDICAL SYSTEM
     12.17 ROBIMES INDIA PVT. LTD.
     12.18 MERIL LIFE SCIENCES PVT. LTD.

*Business overview, Products offered, Recent developments, COVID-19 Impact, MNM view might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 148)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS


LIST OF TABLES (105 Tables)

TABLE 1 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 AND 2050
TABLE 2 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 3 CLINICAL LABORATORY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 CLINICAL LABORATORY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 CLINICAL LABORATORY COAGULATION ANALYZER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 STANDARDS, CONTROLS, AND CALIBRATIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 CLINICAL LABORATORY COAGULATION ANALYZER SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 SEMI-AUTOMATED SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 MANUAL SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 POC TESTING ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 16 PROTHROMBIN TIME TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 D-DIMER TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 FIBRINOGEN TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 ACT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 APTT TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 PLATELET FUNCTION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 ANTI-FACTOR XA TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 OTHER COAGULATION TESTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 26 OPTICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 MECHANICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 28 ELECTROCHEMICAL TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 OTHER TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31 HOSPITALS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 32 CLINICAL LABORATORIES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 OTHER END USERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 COAGULATION ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 40 US: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 41 US: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 42 US: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 43 US: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 44 CANADA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 45 CANADA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 46 CANADA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 47 CANADA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 52 EUROPE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 53 GERMANY: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 54 GERMANY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 55 GERMANY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 56 GERMANY: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 57 UK: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 58 UK: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 59 UK: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 60 UK: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 62 FRANCE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 63 FRANCE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 64 FRANCE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 65 ITALY: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 ITALY: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 67 ITALY: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 68 ITALY: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 SPAIN: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 70 SPAIN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 71 SPAIN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 72 SPAIN: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 ROE: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 74 ROE: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 75 ROE: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 76 ROE: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 APAC: COAGULATION ANALYZERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 APAC: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 APAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 80 ASIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 81 APAC: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 82 CHINA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 83 CHINA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 84 CHINA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 85 CHINA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 86 JAPAN: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 JAPAN: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 88 JAPAN: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 89 JAPAN: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 90 INDIA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 91 INDIA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 92 INDIA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 93 INDIA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 95 ROAPAC: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 96 ROAPAC: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 97 ROAPAC: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 98 LATAM: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 99 LATAM: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 100 LATAM: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 101 LATAM: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 103 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 104 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY TEST, 2018–2025 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA: COAGULATION ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
 
 
LIST OF FIGURES (24 Figures)
 
FIGURE 1 COAGULATION ANALYZERS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 COAGULATION ANALYZERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 COAGULATION ANALYZERS MARKET, BY TEST, 2020 VS. 2025 (USD MILLION)
FIGURE 8 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 9 COAGULATION ANALYZERS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 COAGULATION ANALYZERS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 INCREASING PREVALENCE OF BLOOD DISORDERS TO DRIVE MARKET GROWTH
FIGURE 12 CLINICAL LABORATORY ANALYZERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
FIGURE 13 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
FIGURE 14 COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT
FIGURE 16 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO MARCH 2020
FIGURE 17 COAGULATION ANALYZERS MARKET RANKING ANALYSIS, BY PLAYER, 2019
FIGURE 18 COAGULATION ANALYZERS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 19 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 20 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 21 NIHON KOHDEN: COMPANY SNAPSHOT (2019)
FIGURE 22 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
FIGURE 23 SIEMENS HEALTHINEERS GROUP: COMPANY SNAPSHOT (2019)
FIGURE 24 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)

The study involved four major activities for estimating the current size of the coagulation analyzers market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Coagulation Analyzers Market - Primary Participants

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the coagulation analyzers market. Other MnM proprietary reports were also referred to estimate the market size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the market have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size - using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the coagulation analyzers industry.

Report Objectives

  • To define, describe, and forecast the coagulation analyzers market on the basis of test, product, technology, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall coagulation analyzers market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the global coagulation analyzers market with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the coagulation analyzers market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as partnerships, agreements, and collaborations; acquisitions; expansions; and product launches & approvals in the coagulation analyzers market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Further split for LATAM and MEA countries

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of top companies

COVID-19

Get in-depth analysis of the COVID-19 impact on the Hemostasis/Coagulation Analyzer Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Hemostasis/Coagulation Analyzer Market

Request For Special Pricing
Report Code
AST 7689
Published ON
Jun, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hemostasis/Coagulation Analyzer Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home